Human Microbiome Market Size, Share | Report 2021, 2028
人类微生物组市场预计将从 2021 年的 7.1895 亿美元增至 2028 年的 29.2168 亿美元;预计 2021-2028 年期间的复合年增长率为 22.2%。
人类微生物群由每个人体内数以万亿计的共生微生物细胞组成,主要是肠道细菌。包括细菌、真菌和病毒在内的微生物是致病因子,它们会随着时间的推移而积累,肠道栖息地会改变它们的遗传活动和代谢过程,导致对人体内正常存在的物质和组织产生异常的免疫反应。全球已启动多个微生物组项目,旨在了解这些共生体所起的作用及其对人类宿主健康的影响。人类微生物组市场的增长归因于生活方式疾病发病率的增加、对人类微生物组疗法的日益关注以及宏基因组学和下一代测序技术的不断进步等因素。然而,严格的政府指导方针和对详细检查知识的缺乏阻碍了市场的增长。
市场洞察
生活方式疾病发病率不断上升
在过去的几十年里,研究人员已经明确了人类微生物组与癌症、糖尿病、肥胖症和抑郁症等生活方式疾病之间的关系。生活方式和社会规范的变化会影响生命各个阶段的微生物组。改变人类微生物组有助于消除此类生活方式疾病。根据世界卫生组织的数据,2016 年世界人口(成年人)中有 13% 是肥胖症患者。根据 2016 年发表的《肥胖和代谢紊乱治疗的新时代:肠道微生物组移植的证据和期望》,人类胃肠道中的微生物充当内分泌器官,其组成和功能有助于肥胖症的发展。因此,粪便/肠道微生物组移植 (GMT),即从健康捐赠者向患者移植粪便,是一种潜在的肥胖治疗方法。
糖尿病是21世纪全球卫生紧急事件之一。根据国际糖尿病联盟 (IDF) 的数据,2017年北美糖尿病患者人数约为4600万,预计到2045年将上升至6200万,即预测期内患病率约为35%。厚壁梭菌水平的降低表明糖尿病患者的微生物群中存在产丁酸细菌,拟杆菌门:厚壁梭菌门的比例增加。因此,可以通过施用益生元、益生菌和粪便移植来改变微生物群,从而预防和治疗糖尿病。因此,慢性生活方式疾病发病率的上升正在推动人类微生物群市场的增长。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
人类微生物组市场:
Human Microbiome Market: Strategic Insights
Human Microbiome Market
-
CAGR (2021 - 2028)
22.2%
-
Market Size 2021
US$ 718.95 Million
-
Market Size 2028
US$ 2,921.68 Million
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Rebiotix Inc
- Yakult Honsha Co Ltd
- Synthetic Biologics Inc
- DuPont
- MaaT Pharma
- Eligo Bioscience
- Merck Co Inc
- AOBiome LLC
- Kaleido
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
产品(益生菌、食品、益生元、医疗食品、诊断设备、药物和补充剂)
疾病(肥胖症、糖尿病、自身免疫性疾病、癌症、精神障碍等)
应用(治疗学和诊断学)
地理(北美洲、欧洲、亚太地区、中东和非洲、南美洲和中美洲)
Microbiome Market:
Human Microbiome Market: Strategic Insights
-
CAGR (2021 - 2028)22.2% -
Market Size 2021
US$ 718.95 Million -
Market Size 2028
US$ 2,921.68 Million
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Rebiotix Inc
- Yakult Honsha Co Ltd
- Synthetic Biologics Inc
- DuPont
- MaaT Pharma
- Eligo Bioscience
- Merck Co Inc
- AOBiome LLC
- Kaleido
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
复合年增长率(2021 - 2028 年)22.2%- 2021 年市场规模
7.1895 亿美元 - 2028 年市场规模
29.2168 亿美元
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- Rebiotix 公司
- 养乐多本社株式会社
- 合成生物制剂公司
- 杜邦
- MaaT 制药
- Eligo 生物科学
- 默克公司
- 生物医学工程有限公司
- 万花筒
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 益生菌
- 食物
- 益生元
- 医疗食品
- 诊断设备
- 药物和补品
- 肥胖
- 糖尿病
- 自身免疫性疾病
- 癌症
- 精神错乱
- 其他的
- 治疗和诊断
- 北美
- 欧洲
- 亚太地区
- 中东和非洲
- 南美洲和中美洲
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
基于产品的洞察
根据产品,人类微生物组市场细分为食品、医疗食品、益生菌、益生元、药物、诊断设备和补充剂。益生菌部分预计将在 2021 年占据最大的市场份额,而益生元部分预计将在预测期内实现最高的复合年增长率。
报告范围
基于疾病的见解
人类微生物组市场按疾病分为糖尿病、癌症、自身免疫性疾病、肥胖症、精神障碍和其他疾病。由于癌症和糖尿病等生活方式疾病的发病率不断上升,人类微生物组市场正在兴起。肥胖症部分预计将在 2021 年占据最大的市场份额,而糖尿病部分预计在预测期内的复合年增长率最高。
基于应用的洞察
人类微生物组市场按应用分为诊断和治疗两大类。治疗领域预计在 2021 年将占据更大的市场份额,并且预计在预测期内将录得更高的复合年增长率。
产品发布和批准是公司扩大全球足迹和产品组合的常用策略。人类微生物组市场中的公司专注于合作策略来扩大客户群,这反过来又使他们能够在全球范围内保持自己的品牌名称。
人类微生物组市场报告范围
报告属性 | 细节 |
---|---|
2021 年市场规模 | 7.1895亿美元 |
2028 年市场规模 | 29.2168亿美元 |
全球复合年增长率(2021 - 2028) | 22.2% |
历史数据 | 2019-2020 |
预测期 | 2022-2028 |
涵盖的领域 | 按产品
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
人类微生物组市场 – 按产品分类
- 益生菌
- 食物
- 益生元
- 医疗食品
- 诊断设备
- 药物
- 补充剂
人类微生物组市场 – 按疾病分类
- 肥胖
- 糖尿病
- 自身免疫性疾病
- 癌症
- 精神错乱
- 其他的
人类微生物组市场 – 按应用
- 疗法
- 诊断
人类微生物组市场——按地区划分
北美
- 我们
- 加拿大
- 墨西哥
欧洲
- 法国
- 德国
- 意大利
- 英国
- 西班牙
- 欧洲其他地区
亚太地区 (APAC)
- 中国
- 印度
- 韩国
- 日本
- 澳大利亚
- 亚太其他地区
中东和非洲 (MEA)
- 南非
- 沙特阿拉伯
- 阿联酋
- 中东和非洲其他地区
南美洲和中美洲(SCAM)
- 巴西
- 阿根廷
- 南美洲和中美洲其他地区
公司简介
- Rebiotix 公司
- 养乐多本社株式会社
- 合成生物制剂公司
- 杜邦
- MaaT 制药
- Eligo 生物科学
- 默克公司
- 生物医学工程有限公司
- 万花筒
- Seres 治疗公司
Human Microbiome Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 718.95 Million |
Market Size by | US$ 2,921.68 Million |
Global CAGR | 22.2% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 产品(益生菌、食品、益生元、医疗食品、诊断设备、药物和补充剂) |
Regions and Countries Covered |
北美(美国、加拿大、墨西哥)
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The growth of the human microbiome market is attributed to the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies, and growing technological advancements in metagenomics and next-generation sequencing. However strict government guidelines and lack of knowledge about detailed examination hinders the market growth.
The human microbiota consists of the trillions of symbiotic microbial cells harbored by each person, mainly bacteria in the gut. The microbes including bacteria, fungi and viruses are the disease-causing microbes that accumulate over time and changing their gene activity & metabolic processes and resulting in an abnormal immune response against the substances and tissues that normally present in the human body.
The Asia Pacific human microbiome market is analyzed based on the five major countries such as China, Japan, India, Australia, South Korea, and the rest of Asia Pacific. The Asia Pacific region is expected to be the fastest-growing region among all other regions. The rise in the collaborations among the Asian countries and Western countries for the research activities and the extensive genomic research in China are to likely drive the human microbiome market in the forecast period. In May 2018, The Conference on Human Microbiome and Chronic Disease, hosted by the Institute of Microbiology, Chinese Academy of Sciences and Chinese Society of Biotechnology was held in China National Convention Center at Beijing. The aim was to promote research human microbiome and related technology. Thus, there is a huge potential for human microbiome market in the region during the forecast period owing to the above-mentioned factors.
The List of Companies - Human Microbiome Market
- Rebiotix Inc.
- Yakult Honsha Co., Ltd.
- Synthetic Biologics Inc.
- DuPont
- MaaT Pharma
- Eligo Bioscience
- Merck & Co. Inc
- AOBiome LLC
- Kaleido
- Seres Therapeutics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.